This study aims at evaluating the efficacy and safety of methylphenidate in the initial
treatment of acute mania in patients with bipolar affective disorders.
Phase:
Phase 3
Details
Lead Sponsor:
Michael Kluge
Collaborators:
Spanish Clinical Research Network - CAIBER Spanish Clinical Research Network - SCReN